Abstract
Using immunohistochemical and enzyme biochemical methods we investigated the expression of L- and M2-pyruvate kinase (PK) in normal renal tissue, renal cell carcinomas (RCCs; of clear cell, chromophilic cell and mixed cell type) and RCC metastases. L-PK was expressed in the proximal tubules of normal renal tissue and, to a variable extent, in 23/25 primary RCCs, in 1 RCC recurrence and in 10 RCC metastases. Staining intensity and percentage of stained tissue did not correlate with tumour grade. One renal oncocytoma and all extrarenal malignancies examined lacked L-PK immunoreactivity. M2-PK was mainly expressed in the distal tubules of the normal kidney and was found in all renal tumours as well as extrarenal malignancies. Quantitative biochemical investigations yielded a two- to seventeen-fold increase in PK activity in RCCs compared to the normal renal cortex taken from the same patient, whereas fructose-1,6-bisphosphatase and cytosolic glycerol-3-phosphate dehydrogenase activity was dramatically lower in RCCs. Otherwise, the activity of all other enzymes investigated (glucose-6-phosphate dehydrogenase, enolase and lactate dehydrogenase) was not significantly changed in the RCCs. The immunocytochemical results suggest that L-PK is a useful marker for RCC and its metastases, if acetone-fixed tissue is available. The quantitative changes of the concentration of PK and other enzymes in RCCs when compared with normal renal tissue probably reflect metabolic alterations related to tumour growth.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahn YS, Zerban H, Grobholz R, Bannasch P (1992) Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney. Carcinogenesis 13:2329–2334
Aithal HN, Toback FG, Cryst C (1980) Enhancement of renal medullary pyruvate kinase activity during cell proliferation induced by potassium depletion. Am J Physiol 238:377–388
Ang LC, Debowski T, Michalski R (1991) Immunolocalization of prealbumin (transthyretin) in renal cell carcinoma. Histopathology 18:565–568
Beckner ME, Stracke ML, Liotta LA, Schiffmann E (1990) Glycolysis as primary energy source in tumor cell chemotaxis. J Natl Cancer Inst 82:1836–1840
Board M, Humm S, Newsholme EA (1990) Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem J 265:503–509
Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229
Debruyne FMJ, Franssen MPH, Beniers A JMC, Schalken JA, Mulder PHM (1990) New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data. Prog Clin Biol Res 350:243–255
Eigenbrodt E, Fister P, Reinacher M (1985) New perspectives on carbohydrate metabolism in tumor cells. In: Bettner R (ed) Regulation of carbohydrate metabolism. vol 2, CRC Press, Boca Raton, pp. 141–179
Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R (1992) Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog 3:91–115
Fischer G, Holzrichter S, Reinacher M, Heinrichs M, Dembowski J, Eigenbrodt E (1989) Immunhistochemische Darstellung der L- und M2-Pyruvatkinase in primären Nierenzellkarzinomen und deren Metastasen. Verh Dtsch Ges Pathol 73:422–427
Fischer P, Störkel S, Haase W, Scherberich JE (1991) Differential diagnosis of histogenetically distinct human epithelial renal tumors with a monoclonal antibody against gamma-glutamyl-transferase. Cancer Immunol Immunother 33:382–388
Gebracht U, Roth E, Becker K, Reinacher M, Eigenbrodt E (1988) A study of the activities of carbohydrate-metabolizing enzymes and the levels of carbohydrate metabolites and amino acids in normal liver and in hepatocellular carcinoma. In: Roberfroid MB, Preat V (eds) Experimental hepatocarcinogenesis, Plenum, pp. 163–174
Haas GP, Hillman GG, Redman BG, Pontes JE (1993) Immunotherapy of renal cell carcinoma. CA 43:177–187
Haimoto H, Takashi M, Koshikawa T, Asai J, Kato K (1986) Enolase isozymes in renal tubules and renal cell carcinoma. Am J Pathol 124:488–495
Hugo F, Mazurek S, Zander U, Eigenbrodt E (1992) In vitro effect of extracellular AMP on MCF-7 breast cancer cells: inhibition of glycolysis and cell proliferation. Cell Physiol 153:539–549
Mazurek S, Scheefers-Borchel U, Scheefers H, Michel A, Basenau D, Fischer G, Dahlmann N, Laumen R, Eigenbrodt E (1993) Die Bedeutung der Pyruvatkinase in der Onkologie. notabene medici 3:97–104
Nogueira E, Bannasch P (1988) Cellular origin of rat renal oncocytoma. Lab Invest 59:337–343
Oosterwijk E, Ruiter DJ, Wakka JC, Huiskens van der Meij JW, Jonas U, Fleuren GJ, Zwartendijk J, Hoedemaeker PH, Warnaar SO (1986) Immunhistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am J Pathol 123:301–309
Ortmann M, Vierbuchen M, Fischer R (1991) Sialylated glycoconjugates in chromophobe cell renal carcinoma compared with other renal cell tumours: indication of its development from the collecting duct epithelium. Virchows Arch [B] 61:123–132
Quesada JR (1989) Role of interferons in the therapy of metastatic renal cell carcinoma. Urology 34 [suppl]:80–83
Reinacher M (1983) Immunhistologischer Nachweis pathologischer Veränderungen des Pyruvatkinase-Enzymgehaltes in Organen und Tumoren bei Huhn und Ratte. Med Vet Habil-Schr Gießen
Reinacher M, Eigenbrodt E (1981) Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-PK) in tumors of chicken and rat. Virchows Arch [A] 37:79–88
Rugarli C (1989) Progress in therapy of renal Cancer. Eur J Cancer Clin Oncol 25 [suppl 3]:519–523
Stein H, Gatter K, Asbahr H, Mason DY (1985) Methods in laboratory investigation. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest 52:676–683
Steinberg P, Störkel S, Oesch F, Thoenes W (1992) Carbohydrate metabolism in human renal clear cell carcinomas. Lab Invest 67:506–511
Störkel S (1993) Carcinomas and oncocytomas of the kidney: phenotypical characteristics and prognostic aspects. In: Denk H et al. (eds) Progress in pathology. Gustav Fischer, Stuttgart, pp 123–125
Störkel S, Jakobi GH (1989) Systematik, Histogenese und Prognose der Nierenzellkarzinome und des renalen Onkozytoms des Menschen. Verh Dtsch Ges Pathol 73:321–338
Störkel S, Steart PV, Drenckhahn D, Thoenes W (1989) The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch [B] 56:237–245
Thoenes W, Störkel ST, Rumpelt HJ (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125–143
Thoenes W, Störkel S, Rumpelt JH, Moll R, Baum HP, Werner S (1989) Chromophobe cell renal carcinoma and its variants — a report of 32 cases. J Pathol 155:277–287
Vessella RL, Moon TD, Chiou RK, Nowak JA, Arfman EW, Palme DF, Peterson GA, Lange PH (1985) Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens. Cancer Res 45:6131–6139
Yoshida SO, Imam A (1989) Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcionomas. Cancer Res 49:1802–1809
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brinck, U., Fischer, G., Eigenbrodt, E. et al. L- and M2- pyruvate kinase expression in renal cell carcinomas and their metastases. Vichows Archiv A Pathol Anat 424, 177–185 (1994). https://doi.org/10.1007/BF00193498
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00193498